|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is supported by an
educational grant from GlaxoSmithKline
PLEASE CLICK HERE TO VIEW PRESENTATION
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: View the presentation, answer the
post test, complete the evaluation form and submit to
keads@namcp.org. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Summary
Restless legs syndrome (RLS) is a prevalent but frequently under
diagnosed disorder. It can be a primary or secondary disorder that
causes significant patient burden. Dopamine agonists are generally
first-choice therapy. Ropinirole and pramipexole are effective, FDA
approved medications for RLS.
Objectives
-
Define Restless Legs
Syndrome (RLS)
-
Identify disease states
that may cause RLS
-
Discuss the impact of RLS
on the patient’s overall health status
-
Review research being
done about RLS
|
Faculty: |
Michael Thorpy, MD,
Sleep-Wake Disorders Center Montefiore Medical Center &
Albert Einstein College of Medicine, Bronx, NY |
| |
|
|
Disclosure:
|
Dr. Thorpy serves on the
speakers bureau for Boehringer Ingeheim and
GlaxoSmithKline. |
Accreditation & Designation
The National Association of Managed
Care Physicians (NAMCP) is accredited by the Accreditation Council
for Continuing Medical Education to sponsor continuing medical
education for physicians. NAMCP designates this activity for a
maximum of 1 AMA PRA Category I creditsTM. Each physician should
claim credit commensurate with the extent of their participation in
the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA) VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1.0 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is
supported by an educational grant from GlaxoSmithKline
|